| Primary |
| Colitis Ulcerative |
64.0% |
| Crohn's Disease |
16.0% |
| Hiv Infection |
8.0% |
| Colitis |
4.0% |
| Diverticulum |
4.0% |
| Product Used For Unknown Indication |
4.0% |
|
| Diarrhoea |
11.5% |
| Pancreatitis Acute |
11.5% |
| Maternal Drugs Affecting Foetus |
7.7% |
| Pericarditis |
7.7% |
| Alopecia |
3.8% |
| Cardiac Disorder |
3.8% |
| Chest Pain |
3.8% |
| Dyspnoea |
3.8% |
| Hepatic Enzyme Increased |
3.8% |
| Lethargy |
3.8% |
| Myocardial Infarction |
3.8% |
| Nephritis |
3.8% |
| Pancreatitis |
3.8% |
| Pneumonitis |
3.8% |
| Product Substitution Issue |
3.8% |
| Pyrexia |
3.8% |
| Renal Failure |
3.8% |
| Schizophrenia |
3.8% |
| Sinusitis |
3.8% |
| Skin Ulcer |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
53.2% |
| Crohn's Disease |
31.9% |
| Ankylosing Spondylitis |
2.1% |
| Atrial Fibrillation |
2.1% |
| Coccidioidomycosis |
2.1% |
| Colitis Ulcerative |
2.1% |
| Constipation |
2.1% |
| Diastolic Hypertension |
2.1% |
| Hypertension |
2.1% |
|
| Lethargy |
27.3% |
| Polyp |
27.3% |
| Crohn's Disease |
9.1% |
| Drug Ineffective |
9.1% |
| Headache |
9.1% |
| Intestinal Stenosis |
9.1% |
| Pancreatitis |
9.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.0% |
| Crohn's Disease |
28.6% |
| Colitis Ulcerative |
10.3% |
| Pain |
2.6% |
| Hypertension |
2.5% |
| Depression |
2.0% |
| Vitamin Supplementation |
1.8% |
| Anxiety |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Colitis |
1.6% |
| Diabetes Mellitus |
1.6% |
| Blood Cholesterol Increased |
1.3% |
| Asthma |
0.9% |
| Sleep Disorder |
0.9% |
| Hypersensitivity |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Anaemia |
0.8% |
| Lung Disorder |
0.7% |
| Pain Management |
0.7% |
| Mineral Supplementation |
0.6% |
|
| Injection Site Pain |
19.3% |
| Diarrhoea |
7.6% |
| Influenza |
6.9% |
| Weight Decreased |
6.9% |
| Pyrexia |
6.2% |
| Unevaluable Event |
5.5% |
| Crohn's Disease |
4.1% |
| Drug Ineffective |
4.1% |
| Rash |
4.1% |
| Rectal Haemorrhage |
4.1% |
| Injection Site Swelling |
3.4% |
| Nausea |
3.4% |
| Off Label Use |
3.4% |
| Sinusitis |
3.4% |
| Vomiting |
3.4% |
| Colitis Ulcerative |
2.8% |
| Fatigue |
2.8% |
| Infection |
2.8% |
| Injection Site Haemorrhage |
2.8% |
| Migraine |
2.8% |
|
| Interacting |
| Colitis Ulcerative |
43.2% |
| Product Used For Unknown Indication |
12.3% |
| Contraception |
11.1% |
| Cough |
11.1% |
| Inflammatory Bowel Disease |
11.1% |
| Vitamin Supplementation |
6.2% |
| Supplementation Therapy |
4.9% |
|
| Arthralgia |
11.1% |
| Drug Interaction |
11.1% |
| Gastrointestinal Inflammation |
11.1% |
| Nephritis |
11.1% |
| Oedema Mouth |
11.1% |
| Oropharyngeal Pain |
11.1% |
| Pruritus |
11.1% |
| Red Blood Cell Sedimentation Rate Increased |
11.1% |
| Stomatitis |
11.1% |
|
